SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
斯佳丽奥哈拉
Lv1
70 积分
2021-08-31 加入
最近求助
最近应助
互助留言
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
10天前
已完结
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
10天前
已完结
[Chinese expert consensus of antibody-drug conjugate toxicity management for breast cancer]
25天前
已完结
Upregulation of Trop-2 quantitatively stimulates human cancer growth
25天前
已完结
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
26天前
已关闭
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
26天前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?
1个月前
已关闭
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
1个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
1个月前
已完结
没有进行任何应助
已找到【积分已退回】
26天前
文章错了【积分已退回】
1个月前
帮大忙了,速度真快
6个月前
需要slides或者原文
8个月前
点赞,点赞,速度真快
1年前
感谢,点赞,速度真快
1年前
帮大忙了
2年前
帮大忙了
2年前
感谢,速度真快,帮大忙了
2年前
帮大忙了,么么哒
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论